For: | Czaja AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol 2016; 22(42): 9257-9278 [PMID: 27895415 DOI: 10.3748/wjg.v22.i42.9257] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i42/9257.htm |
Number | Citing Articles |
1 |
Lavanya Reddivari, D. N. Rao Veeramachaneni, William A. Walters, Catherine Lozupone, Jennifer Palmer, M. K. Kurundu Hewage, Rohil Bhatnagar, Amnon Amir, Mary J. Kennett, Rob Knight, Jairam K. P. Vanamala, Thomas Sharpton. Perinatal Bisphenol A Exposure Induces Chronic Inflammation in Rabbit Offspring via Modulation of Gut Bacteria and Their Metabolites. mSystems 2017; 2(5) doi: 10.1128/mSystems.00093-17
|
2 |
Ma Liang, Zhang Liwen, Song Jianguo, Dai Juan, Ding Fei, Zhang Yin, Wu Changping, Chen Jianping. Fecal Microbiota Transplantation Controls Progression of Experimental Autoimmune Hepatitis in Mice by Modulating the TFR/TFH Immune Imbalance and Intestinal Microbiota Composition. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.728723
|
3 |
Angelo Armandi, Giovanni Clemente Actis, Davide Giuseppe Ribaldone. Translational Autoimmunity. 2022; : 309 doi: 10.1016/B978-0-12-824466-1.00012-1
|
4 |
Rachel E. Crossland, Francesca Perutelli, Katarzyna Bogunia-Kubik, Nuala Mooney, Nina Milutin Gašperov, Maja Pučić-Baković, Hildegard Greinix, Daniela Weber, Ernst Holler, Dražen Pulanić, Daniel Wolff, Anne M. Dickinson, Marit Inngjerdingen, Magdalena Grce. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.602547
|
5 |
Jingshu Yang, Wentao Xie, Kangkang Yu, Qi Cheng, Guangfeng Shi, Ning Li. Methyl butyrate attenuates concanavalin A-induced autoimmune hepatitis by inhibiting Th1-cell activation and homing to the liver. Cellular Immunology 2022; 378: 104575 doi: 10.1016/j.cellimm.2022.104575
|
6 |
Tanuj Upadhyay, Shvetank Bhatt. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. 2022; : 93 doi: 10.1007/978-981-19-1946-6_5
|
7 |
Albert J. Czaja. Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination. Clinical Liver Disease 2020; 15(S1): S72 doi: 10.1002/cld.917
|
8 |
Sangeeta Khare, Kuppan Gokulan, Katherine Williams, Shasha Bai, Kathleen M. Gilbert, Sarah J. Blossom. Irreversible effects of trichloroethylene on the gut microbial community and gut‐associated immune responses in autoimmune‐prone mice. Journal of Applied Toxicology 2019; 39(2): 209 doi: 10.1002/jat.3708
|
9 |
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
|
10 |
Sabeen Abid Khan, Naurin Ali, Muhammad Arslan Farooq, Shamama Hasan, Munir Iqbal Malik. Spectrum of Pediatric Autoimmune Hepatitis in a Cohort of Pakistani Children. Global Pediatric Health 2024; 11 doi: 10.1177/2333794X241251644
|
11 |
Jin-Lu Wu, Jia-Yun Zou, En-De Hu, Da-Zhi Chen, Lu Chen, Feng-Bin Lu, Lan-Man Xu, Ming-Hua Zheng, Hui Li, Yu Huang, Xiao-Ya Jin, Yue-Wen Gong, Zhuo Lin, Xiao-Dong Wang, Ming-Fang Zhao, Yong-Ping Chen. Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway. Immunology Letters 2017; 190: 169 doi: 10.1016/j.imlet.2017.08.005
|
12 |
Albert J Czaja. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease. World Journal of Gastroenterology 2021; 27(25): 3705-3733 doi: 10.3748/wjg.v27.i25.3705
|
13 |
Zejin Liu, Mengyang Sun, Wenhua Liu, Fangyu Feng, Xinyu Li, Chaolei Jin, Yijie Zhang, Junpeng Wang. Deficiency of purinergic P2X4 receptor alleviates experimental autoimmune hepatitis in mice. Biochemical Pharmacology 2024; 221: 116033 doi: 10.1016/j.bcp.2024.116033
|
14 |
Susan S. Baker, Robert D. Baker. Gut Microbiota and Pathogenesis of Organ Injury. Advances in Experimental Medicine and Biology 2020; 1238: 39 doi: 10.1007/978-981-15-2385-4_4
|
15 |
Sunil J. Wimalawansa. Controlling Chronic Diseases and Acute Infections with Vitamin D Sufficiency. Nutrients 2023; 15(16): 3623 doi: 10.3390/nu15163623
|
16 |
Amber BOZWARD, Maurizio CE, Liliana DELL’ORO, Ye H. OO, Vincenzo RONCA. Breakdown in hepatic tolerance and its relation to autoimmune liver diseases. Minerva Gastroenterology 2023; 69(1) doi: 10.23736/S2724-5985.21.02853-1
|
17 |
Annarosa Floreani, Paula Restrepo-Jiménez, Maria Francesca Secchi, Sara De Martin, Patrick S.C. Leung, Edward Krawitt, Christopher L. Bowlus, M. Eric Gershwin, Juan-Manuel Anaya. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 2018; 95: 133 doi: 10.1016/j.jaut.2018.10.020
|
18 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 2024; 6(1): 64 doi: 10.3390/gidisord6010005
|
19 |
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/9437043
|
20 |
Giorgina Mieli-Vergani, Diego Vergani, Albert J. Czaja, Michael P. Manns, Edward L. Krawitt, John M. Vierling, Ansgar W. Lohse, Aldo J. Montano-Loza. Autoimmune hepatitis. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/nrdp.2018.17
|
21 |
Yuanyuan Su, Ning Lu, Qian Li, Hua Wen, Xiao Qin Zhang, Mingxin Zhang, Jian Wu. Gut Microbiota and Drug-Related Liver Injury: Challenges and Perspectives. Advanced Gut & Microbiome Research 2023; 2023: 1 doi: 10.1155/2023/5442597
|
22 |
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, Aida Ortega-Alonso, M. Isabel Lucena, Raúl J. Andrade. Drug induced liver injury: an update. Archives of Toxicology 2020; 94(10): 3381 doi: 10.1007/s00204-020-02885-1
|
23 |
Kerri Glassner, Eamonn MM Quigley, Lissa Franco, David W Victor III. Autoimmune liver disease and the enteric microbiome. AIMS Microbiology 2018; 4(2): 334 doi: 10.3934/microbiol.2018.2.334
|
24 |
Xindi Wei, Xiaoyin Niu. T follicular helper cells in autoimmune diseases. Journal of Autoimmunity 2023; 134: 102976 doi: 10.1016/j.jaut.2022.102976
|
25 |
Albert J. Czaja. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis. Digestive Diseases and Sciences 2022; 67(4): 1163 doi: 10.1007/s10620-021-06968-6
|
26 |
Monica Centa, Erica G. Weinstein, Jose C. Clemente, Jeremiah J. Faith, M. Isabel Fiel, Robby Lyallpuri, Olivier Herbin, Konstantina Alexandropoulos. Impaired central tolerance induces changes in the gut microbiota that exacerbate autoimmune hepatitis. Journal of Autoimmunity 2022; 128: 102808 doi: 10.1016/j.jaut.2022.102808
|
27 |
Nahla M. Elsherbiny, Mohammed Rammadan, Elham A. Hassan, Mohamed E. Ali, Abeer S. Abd El-Rehim, Wael A. Abbas, Mohamed A. A. Abozaid, Ebtisam Hassanin, Helal F. Hetta. Autoimmune Hepatitis: Shifts in Gut Microbiota and Metabolic Pathways among Egyptian Patients. Microorganisms 2020; 8(7): 1011 doi: 10.3390/microorganisms8071011
|
28 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. HLA, gut microbiome and hepatic autoimmunity. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.980768
|
29 |
Albert J. Czaja. Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis. Digestive Diseases and Sciences 2023; 68(11): 4098 doi: 10.1007/s10620-023-08118-6
|
30 |
Albert J. Czaja. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Digestive Diseases and Sciences 2018; 63(7): 1706 doi: 10.1007/s10620-018-5072-x
|
31 |
Albert J. Czaja. Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis. Digestive Diseases and Sciences 2017; 62(9): 2277 doi: 10.1007/s10620-017-4675-y
|
32 |
泽庆 陈. Recent Advances in Immunological Studies of Intestinal Microbes and Inflammatory Related Diseases. Advances in Microbiology 2018; 7(01): 12 doi: 10.12677/AMB.2018.71002
|
33 |
Weronika Domerecka, Anna Kowalska-Kępczyńska, Agata Michalak, Iwona Homa-Mlak, Radosław Mlak, Halina Cichoż-Lach, Teresa Małecka-Massalska. Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis. Diagnostics 2021; 11(8): 1418 doi: 10.3390/diagnostics11081418
|
34 |
Albert J Czaja. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World Journal of Gastroenterology 2019; 25(45): 6579-6606 doi: 10.3748/wjg.v25.i45.6579
|
35 |
Albert J. Czaja. Evolving paradigm of treatment for autoimmune hepatitis. Expert Review of Clinical Immunology 2017; 13(8): 781 doi: 10.1080/1744666X.2017.1319764
|
36 |
Bastian Engel, Alena Laschtowitz, Maciej K. Janik, Norman Junge, Ulrich Baumann, Piotr Milkiewicz, Richard Taubert, Marcial Sebode. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review. European Journal of Medical Genetics 2021; 64(6): 104214 doi: 10.1016/j.ejmg.2021.104214
|
37 |
Sunil Wimalawansa. Overcoming Infections Including COVID-19, by Maintaining Circulating 25(OH)D Concentrations Above 50 ng/mL. Pathology and Laboratory Medicine International 2022; : 37 doi: 10.2147/PLMI.S373617
|
38 |
A. J. Czaja. Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2017; 46(10): 920 doi: 10.1111/apt.14324
|
39 |
Kazumichi Abe, Atsushi Takahashi, Masashi Fujita, Hiromichi Imaizumi, Manabu Hayashi, Ken Okai, Hiromasa Ohira, Olivier Barbier. Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease. PLOS ONE 2018; 13(7): e0198757 doi: 10.1371/journal.pone.0198757
|
40 |
George Schatz, Erica Kumala, Amita Nathwani. A collaborative integrative and Ayurvedic approach to cirrhosis in the setting of autoantibody negative autoimmune hepatitis: a case report. Advances in Integrative Medicine 2022; 9(2): 136 doi: 10.1016/j.aimed.2021.10.002
|
41 |
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad, Albert J. Czaja. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 2020; 72(2): 671 doi: 10.1002/hep.31065
|
42 |
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; : 199 doi: 10.1007/978-3-030-67951-4_7
|
43 |
Xiao Wei Sun, Hua Zhang, Xiao Zhang, Peng Fei Xin, Xue Gao, Hong Rui Li, Cai Yun Zhou, Wen Min Gao, Xuan Xuan Kou, Jian Gang Zhang, Shiek Ahmed. Liver Microbiome in Healthy Rats: The Hidden Inhabitants of Hepatocytes. Cellular Microbiology 2023; 2023: 1 doi: 10.1155/2023/7369034
|
44 |
Qingqing Liu, Haixia Tian, Yongbo Kang, Yan Tian, Lin Li, Xing Kang, Hao Yang, Yanhong Wang, Jihua Tian, Fan Zhang, Mingwei Tong, Hongyan Cai, Weiping Fan. Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability. The Journal of Nutritional Biochemistry 2021; 98: 108863 doi: 10.1016/j.jnutbio.2021.108863
|
45 |
Kazumichi Abe, Masashi Fujita, Manabu Hayashi, Ken Okai, Atsushi Takahashi, Hiromasa Ohira. Gut and oral microbiota in autoimmune liver disease. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 2019; 65(3): 71 doi: 10.5387/fms.2019-21
|
46 |
Albert J. Czaja. Clinical Epidemiology of Chronic Liver Diseases. 2019; : 251 doi: 10.1007/978-3-319-94355-8_16
|
47 |
Yinglin Xia. The Microbiome in Health and Disease. Progress in Molecular Biology and Translational Science 2020; 171: 309 doi: 10.1016/bs.pmbts.2020.04.003
|
48 |
Hongxia Zhang, Man Liu, Weilong Zhong, Yanping Zheng, Yanni Li, Liping Guo, Yujie Zhang, Ying Ran, Jingwen Zhao, Lu Zhou, Bangmao Wang. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.624360
|
49 |
Yue Ma, Yinsheng Guo, Hailing Ye, Jin Zhang, Yuebin Ke. Perinatal Triclosan exposure in the rat induces long-term disturbances in metabolism and gut microbiota in adulthood and old age. Environmental Research 2020; 182: 109004 doi: 10.1016/j.envres.2019.109004
|
50 |
Albert J. Czaja. Missing Causality and Heritability of Autoimmune Hepatitis. Digestive Diseases and Sciences 2023; 68(4): 1585 doi: 10.1007/s10620-022-07728-w
|
51 |
David M. Chascsa, Elise M. N. Ferré, Yannis Hadjiyannis, Hawwa Alao, Mukil Natarajan, Mariam Quinones, David E. Kleiner, Thomas L. Simcox, Ehsan Chitsaz, Stacey R. Rose, Asa Hallgren, Olle Kampe, Jamie Marko, Rabab O. Ali, Sungyoung Auh, Christopher Koh, Yasmine Belkaid, Michail S. Lionakis, Theo Heller. APECED‐Associated Hepatitis: Clinical, Biochemical, Histological and Treatment Data From a Large, Predominantly American Cohort. Hepatology 2021; 73(3): 1088 doi: 10.1002/hep.31421
|
52 |
Albert J. Czaja. Epigenetic changes and their implications in autoimmune hepatitis. European Journal of Clinical Investigation 2018; 48(4) doi: 10.1111/eci.12899
|
53 |
Nathalie A. Pena Polanco, Kalyan Ram Bhamidimarri. Hepatology. 2025; : 695 doi: 10.1016/B978-0-443-26711-6.00026-3
|
54 |
D. R. Akberova, A. Kh. Odintcova, D. I. Abdulganieva. Evaluation of Small Intestinal Permeability in Patients with Overlap Syndrome (Autoimmune Hepatitis/Primary Biliary Cholangitis). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(1): 51 doi: 10.22416/1382-4376-2023-33-1-51-58
|
55 |
Albert J. Czaja. Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis. Digestive Diseases and Sciences 2023; 68(7): 2824 doi: 10.1007/s10620-023-07967-5
|